Establishment and Verification of Pancreatic Volume Formula Based on Imaging
1 other identifier
observational
300
1 country
1
Brief Summary
This study intends to construct the linear relationship between pancreatic volume and individual attributes (height, weight, width of anterior superior iliac spine, etc.), and to establish and verify the formula of pancreatic volume.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2022
CompletedFirst Posted
Study publicly available on registry
June 8, 2022
CompletedStudy Start
First participant enrolled
September 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 5, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedSeptember 14, 2022
September 1, 2022
Same day
June 5, 2022
September 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pancreatic volume
The total volume of pancreas and the volumes of head, body and tail of pancreas will be calculated by software.
14 days after MRI examination
Study Arms (3)
Healthy people
Healthy people refer to those who exclude pancreatic related diseases, such as acute and chronic pancreatitis, pancreatic trauma, pancreatic tumor, peripancreatic lesions, diabetes and other diseases that may affect the volume of the pancreas.
Chronic pancreatitis
Patients with chronic pancreatitis are considered as study subjects.
Acute pancreatitis
Patients with acute pancreatitis within 144 hours after the onset of typical symptoms are considered as study subjects.
Interventions
Enrolled subjects will be examined with MRI of pancreas, and the volume, length and thickness of coronal plane of pancreas will be measured by software.
Eligibility Criteria
Inpatients meeting the eligibility criteria.
You may qualify if:
- Healthy individuals (excluding pancreatic related diseases, such as acute and chronic pancreatitis, pancreatic trauma, pancreatic tumor, peripancreatic lesions, diabetes and other diseases that may affect the volume of the pancreas);
- Patients with chronic pancreatitis;
- Patients with acute pancreatitis within 144 hours after the onset of typical symptoms (severe persistent epigastric pain).
You may not qualify if:
- suspected to have malignant tumors;
- History of pancreas related surgery or minimally invasive treatment (such as pancreaticoduodenectomy, ERCP, etc.);
- acute exacerbation of chronic pancreatitis;
- pregnant or breastfeeding women;
- patients who refused to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Changhai Hospital
Shanghai, 200433, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liang-hao Hu, MD
Changhai Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 5, 2022
First Posted
June 8, 2022
Study Start
September 5, 2022
Primary Completion
September 5, 2022
Study Completion
December 1, 2022
Last Updated
September 14, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share